Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction

NCT01392105 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: Mesenchymal stem cell
DRUG: Control group

Sponsor

Yonsei University

Collaborators

[object Object]